Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression

被引:138
作者
Zheng, ZM [1 ]
机构
[1] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
RNA; exons; introns; RNA splicing; alternative; gene expression; RNA processing; splicing enhancers; splicing suppressors;
D O I
10.1159/000077096
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Intron removal from a pre-mRNA by RNA splicing was once thought to be controlled mainly by intron splicing signals. However, viral and other eukaryotic RNA exon sequences have recently been found to regulate RNA splicing, polyadenylation, export, and nonsense-mediated RNA decay in addition to their coding function. Regulation of alternative RNA splicing by exon sequences is largely attributable to the presence of two major cis-acting elements in the regulated exons, the exonic splicing enhancer (ESE) and the suppressor or silencer (ESS). Two types of ESEs have been verified from more than 50 genes or exons: purine-rich ESEs, which are the more common, and non-purine-rich ESEs. In contrast, the sequences of ESSs identified in approximately 20 genes or exons are highly diverse and show little similarity to each other. Through interactions with cellular splicing factors, an ESE or ESS determines whether or not a regulated splice site, usually an upstream 3' splice site, will be used for RNA splicing. However, how these elements function precisely in selecting a regulated splice site is only partially understood. The balance between positive and negative regulation of splice site selection likely depends on the cis-element's identity and changes in cellular splicing factors under physiological or pathological conditions. Copyright (C) 2004 National Science Council, ROC and S. Karger AG, Basel.
引用
收藏
页码:278 / 294
页数:17
相关论文
共 184 条
[1]  
Akusjärvi G, 2003, CURR TOP MICROBIOL, V272, P253
[2]   PRESENCE OF NEGATIVE AND POSITIVE CIS-ACTING RNA SPLICING ELEMENTS WITHIN AND FLANKING THE FIRST TAT CODING EXON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
AMENDT, BA ;
HESSLEIN, D ;
CHANG, LJ ;
STOLTZFUS, CM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3960-3970
[3]  
AMENDT BA, 1995, MOL CELL BIOL, V15, P4606
[4]  
Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9
[5]   Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene [J].
Aznarez, I ;
Chan, EM ;
Zielenski, J ;
Blencowe, BJ ;
Tsui, LC .
HUMAN MOLECULAR GENETICS, 2003, 12 (16) :2031-2040
[6]   DIFFERENTIATION-SPECIFIC ALTERNATIVE SPLICING OF BOVINE PAPILLOMAVIRUS LATE MESSENGER-RNAS [J].
BARKSDALE, SK ;
BAKER, CC .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6553-6556
[7]   Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system [J].
Battaglia, G ;
Princivalle, A ;
Forti, F ;
Lizier, C ;
Zeviani, M .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1961-1971
[8]   SPLICED SEGMENTS AT 5' TERMINUS OF ADENOVIRUS 2 LATE MESSENGER-RNA [J].
BERGET, SM ;
MOORE, C ;
SHARP, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (08) :3171-3175
[9]   EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[10]   RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element [J].
Bilodeau, PS ;
Domsic, JK ;
Mayeda, A ;
Krainer, AR ;
Stoltzfus, CM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8487-8497